Peptide Library

FDA-approved

Hormones & metabolism

Elamipretide

Evidence

FDA approved

Class

Mitochondria-targeted tetrapeptide

/

Elamipretide

KEY TAKEAWAY

Elamipretide is a small four-amino-acid peptide that concentrates in mitochondria and binds a lipid called cardiolipin. It is sold as Forzinity. The FDA granted accelerated approval to elamipretide (Forzinity) in 2025 for Barth syndrome. Continued approval depends on confirmatory evidence.

Written by the Veylo editorial team · Updated

November 2026

At a glance

At a glance

What it is

Mitochondria-targeted tetrapeptide

Approved for

Barth syndrome

Key fact

The FDA granted accelerated approval to elamipretide (Forzinity) in 2025 for Barth syndrome. Continued approval depends on confirmatory evidence.

Route

Daily subcutaneous injection

Evidence strength

FDA approved

What it is

What it is

Elamipretide is a small four-amino-acid peptide that concentrates in mitochondria and binds a lipid called cardiolipin. It is sold as Forzinity.

How it works

How it works

By binding cardiolipin, it is thought to stabilize the inner mitochondrial membrane and help cells make energy more efficiently.

Regulatory status

Regulatory status

The FDA granted accelerated approval to elamipretide (Forzinity) in 2025 for Barth syndrome. Continued approval depends on confirmatory evidence.

What it is used for

What it is used for

Barth syndrome.

Side effects and risks

Side effects and risks

Injection-site reactions were the most common side effects.

Citations

Citations

U.S. FDA prescribing information for Elamipretide. DailyMed, National Library of Medicine.

Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.

Veylo

Clinician-guided peptide care, paired with baseline blood testing and ongoing support.

Peptides referenced on this site are compounded medications and are investigational; they have not been approved by the FDA for the uses described. Nothing here is medical advice. Prescriptions are issued only after a licensed clinician reviews your history.

© 2026 Veylo. All rights reserved.

Veylo

Veylo

Veylo